(NASDAQ: HYPR) Hyperfine's forecast annual revenue growth rate of 34.29% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.92%, and it is also forecast to beat the US market's average forecast revenue growth rate of 16.52%.
Hyperfine's revenue in 2026 is $15,329,000.On average, 5 Wall Street analysts forecast HYPR's revenue for 2026 to be $2,041,693,001, with the lowest HYPR revenue forecast at $1,945,698,586, and the highest HYPR revenue forecast at $2,135,801,279. On average, 4 Wall Street analysts forecast HYPR's revenue for 2027 to be $2,663,026,034, with the lowest HYPR revenue forecast at $2,529,408,161, and the highest HYPR revenue forecast at $2,772,620,484.
In 2028, HYPR is forecast to generate $3,533,825,421 in revenue, with the lowest revenue forecast at $3,395,244,032 and the highest revenue forecast at $3,637,761,463.